Cognitive enhancing drugs are needed to treat the cognitive impairments associated with debilitating neuropsychiatric disorders, such as Alzheimer’s disease, schizophrenia and attention deficit hyperactivity disorder. Such treatments will improve the quality of life and wellbeing for patients and their families and reduce the financial burden on society. Read more … Talk: The Neuroethics of Smart Drugs